Preclinical studies to improve targeted radionuclide therapy for prostate cancer

Eline Ruigrok

Research output: Types of ThesisDoctoral ThesisInternal

252 Downloads (Pure)

Abstract

The aim of the studies described in this thesis is to investigate methods to improve the therapeutic efficacy and safety of PCa targeting tracers by comparing and selecting the most optimal PCa targeting tracer, by exploring combined PCa-TRT with radiosensitizing strategies, by analyzing the effects of different therapeutic radionuclides, and lastly by identifying the acute, early and/or late radiotoxic effects caused by PCa-TRT. The results of these studies together have increased the general knowledge of PCa-TRT for PCa cancer, which will aid the development and improvement of the currently clinical available treatment options for PCa patients.
Original languageEnglish
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • de Jong, Marion, Supervisor
  • Verburg, Frederik Anton, Supervisor
  • Nonnekens, Julie, Co-supervisor
  • van Weerden, Wytske, Co-supervisor
Award date21 Mar 2023
Place of PublicationRotterdam
Print ISBNs978-94-6419-725-9
Publication statusPublished - 21 Mar 2023

Fingerprint

Dive into the research topics of 'Preclinical studies to improve targeted radionuclide therapy for prostate cancer'. Together they form a unique fingerprint.

Cite this